PRIDD vs PO

Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new and unique measure of the impact of dermatological diseases on the patient’s life and is the first dermatology-specific tool that is applicable to all skin conditions. No other dermatology tool has such broad applicability. PRIDD assesses four dimensions of impact: physical, psychological, life responsibilities and social impacts. PRIDD was developed using a scientifically rigorous and published methodology, resulting in the only dermatology-specific PROM that can be recommended for use according to the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) criteria. PRIDD was developed over seven years in partnership with Cardiff University, University of Hamburg, GlobalSkin and more than 5600 patients living with 90 different dermatological conditions from 96 countries. Each of the development phases of PRIDD have been published in reputable dermatology journals. It the first validated measure in dermatology developed with patients at every step of the process. To learn more about the development of the measure visit https://globalskin.org/research. The entire dermatology community – patients, clinicians, researchers, and pharmaceutical companies – can use PRIDD to better understand patient suffering thereby promoting improved patient-centered healthcare.

POSCORAD allows patients to self assess the severity of their eczema. This app is available in 24 languages. The PO-SCORAD App was designed and developed by the CNRAAC association based on the SCORAD Tool, with the assistance of Professor Jean-François Stalder. •Publisher CNRAAC association, 5 All. de l'Île Gloriette, 44000 Nantes France •Publication Director CNRAAC association Scoring of eczema symptoms that Users enter into the App to calculate the PO-SCORAD Index based on the following criteria: extent of the eczema, intensity of the eczema, severity of the itching and sleep disturbance. Each criterion is assigned a weighting coefficient. Eczema symptom scoring tool that produces the PO-SCORAD Indexes, developed and validated in 1990 by a panel of experts, the European Task Force on Atopic Dermatitis. The App and the PO-SCORAD Index do not provide medical advice, are not a tool to diagnose eczema and in no way constitute a substitute for a medical visit which, alone, can allow for a diagnosis to be made and a treatment protocol to be put in place suited to each individual's needs. The PO-SCORAD Index is calculated based on Scores resulting from self-evaluations. The PO-SCORAD Index is therefore the result of self-evaluation scoring that provides an overview of the severity of the eczema. The App's Information must not be used to provide a medical opinion and replace a visit to a healthcare professional. The Information the App provides is intended to improve - not replace - the relationship that exists between a patient and his or her doctor.